CCTA, CT-MPI, DSA, FFR
2020C03018
Unknown other completed
Quick answer
CCTA, CT-MPI, DSA, FFR for Coronary Microvascular Disease is a Unknown program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Coronary Microvascular Disease
- Phase
- Unknown
- Modality
- other
- Status
- completed